Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Psilocybin in Adults With Major Depressive Disorder (MDD)ClinicalTrials.gov · 2026-10-21Psilocybin produces amplified acute responses and sex-specific long-term increases in sensorimotor gating in the mGlu5 knockout mouse model of schizophrenia.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2026-10-01Worsening of Depression and Anxiety With Psilocybin: A Case Report in Cyclothymia.The Journal of clinical psychiatry · 2026-09-30An Open-Label, Dose-Escalation Trial of Psilocybin-Assisted Therapy for Bipolar II Depression.The Journal of clinical psychiatry · 2026-09-21Psilocybin restores social novelty investigation in male SAPAP3 knockout mice and engages prefrontal-hippocampal circuitry.Molecular psychiatry · 2026-09-17Modulating the Thermodynamics and Kinetics of Psychedelics at Serotonin Receptors via Terahertz WavesThe Journal of Physical Chemistry B · 2026-09-12Active placebo control interventions in pharmacological trials: a scoping review of the development process and a terminological analysis.Journal of clinical epidemiology · 2026-09-01The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisJournal of Affective Disorders · 2026-08-01Efficacy and Safety of a Single Dose of Psilocybin for Chronic Suicidal IdeationThe Journal of Clinical Psychiatry · 2026-05-13Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical ImplicationsFocus · 2026-04-01Comparing single- and repeat-dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trial.Headache · 2026-04-01Patient perspectives on research gaps in cluster headache.Headache · 2026-02-01Psychedelic research and sexuality: opportunities and pitfallsThe Journal of Sexual Medicine · 2026-01-28Contextualizing Violence Risk Associated With Hallucinogens.Focus (American Psychiatric Publishing) · 2026-01-01Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial.PLoS medicine · 2025-09-01Substance Abuse and Cognitive Decline: The Critical Role of Tau Protein as a Potential Biomarker.International journal of molecular sciences · 2025-08-07476. ACUTE AND CHRONIC PSILOCYBIN IN MOUSE MODELS OF PSYCHIATRIC DISORDERSThe international journal of neuropsychopharmacology · 2025-08-01Psychedelic Treatment with Psilocybin: Addressing Medical Malpractice Risk and Physicians' Concerns.The Journal of law, medicine & ethics: a journal of the American Society of Law, Medicine & Ethics · 2025-07-31Ergotamine enhances circadian amplitude and diurnally mitigates nitroglycerin-induced mechanical hypersensitivity.The journal of headache and pain · 2025-05-23The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trialmedRxiv · 2025-03-21Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder.The Journal of clinical psychiatry · 2025-03-03Psychological Support Approaches in Psychedelic Therapy: Results From a Survey of Psychedelic Practitioners.The Journal of clinical psychiatry · 2025-02-05Psilocybin-Assisted Group Psychotherapy + Mindfulness Based Stress Reduction (MBSR) for Frontline Healthcare Provider COVID-19 Related Depression and Burnout: A Randomized Clinical Trial.medRxiv: the preprint server for health sciences · 2025-01-01Plain Language Summary Publication: Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: Results from an open-label phase Ib ascending dose studyHeadache The Journal of Head and Face Pain · 2024-10-09Selective Serotonin Reuptake Inhibitor Discontinuation for Psilocybin Treatment and Contributions to Alcohol Addiction Relapse: A Cautionary Tale.The Journal of clinical psychiatry · 2024-08-26Psilocybin Therapy for Females With Anorexia Nervosa: A Phase 1, Open-Label Feasibility Study.Focus (American Psychiatric Publishing) · 2024-07-01Innovative and Emerging Treatments for Anorexia Nervosa.Focus (American Psychiatric Publishing) · 2024-07-01New perspective on sustained antidepressant effect: focus on neurexins regulating synaptic plasticity.Cell death discovery · 2024-05-01CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity.Headache · 2024-01-01Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: results from an open-label phase Ib ascending dose study.Headache · 2024-01-01HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer.Journal of pain and symptom management · 2023-09-01Have Effective Antidepressants Finally Arrived? Developments in Major Depressive Disorder Therapy.The Journal of clinical psychiatry · 2023-08-14Emerging Perspectives in Addiction Psychiatry.The Journal of clinical psychiatry · 2023-08-09Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trial.Headache · 2022-11-01From Mushrooms to Myolysis: A Case of Rhabdo in Psilocybin-Induced Mood and Psychotic Disorder.The Journal of nervous and mental disease · 2022-08-01Investigation of the neural network responsible for antidepressant effect of serotonergic psychedelicsProceedings for Annual Meeting of The Japanese Pharmacological Society · 2022-01-01Investigation of neuronal basis underlying antidepressant effect of serotonergic psychedelicsProceedings for Annual Meeting of The Japanese Pharmacological Society · 2022-01-01Pharmacologic Similarities and Differences Among Hallucinogens.Journal of clinical pharmacology · 2021-08-01Therapeutic Potential of Psychedelics in Treatment of Psychiatric Disorders, Part 2The Journal of Clinical Psychiatry · 2021-02-23Psychedelics and Psychedelic-Assisted Psychotherapy.Focus (American Psychiatric Publishing) · 2021-01-01Psilocybin: from ancient magic to modern medicine.The Journal of antibiotics · 2020-10-01Moral transhumanism: the next step.The Journal of medicine and philosophy · 2012-08-01Alternative headache treatments: nutraceuticals, behavioral and physical treatments.Headache · 2011-03-01Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.The Journal of clinical psychiatry · 2006-11-01Dissociations between the effects of hallucinogenic drugs on behavior and raphe unit activity in freely moving cats.Brain research · 1981-06-29Application of a radioimmunoassay screening test for detection and management of phencyclidine intoxication.Journal of clinical pharmacology · 1980-01-01LYSERGIC ACID DIETHYLAMIDE (LSD-25). 34. COMPARISON WITH EFFECT OF PSILOCYBIN ON THE SIAMESE FIGHTING FISH.The Journal of psychology · 1963-10-01Comparison of three psychotropic drugs (psilocybin, JB-329, and IT-290) in volunteer subjects.The Journal of nervous and mental disease · 1960-11-01Production of Cross-Tolerance to Psychosis-Producing Doses of Lysergic Acid Diethylamide and PsilocybinThe Journal of Psychology · 1960-01-01